Latest Insider Transactions at Lexaria Bioscience Corp. (LEXX)
This section provides a real-time view of insider transactions for Lexaria Bioscience Corp. (LEXX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Lexaria Bioscience Corp. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Lexaria Bioscience Corp.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2024
|
Richard Christopher Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
27,172
+35.21%
|
$54,344
$2.47 P/Share
|
|
Dec 02
2024
|
Richard Christopher Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
22,828
+50.0%
|
$45,656
$2.24 P/Share
|
|
Aug 12
2024
|
Catherine C. Turkel Director |
BUY
Open market or private purchase
|
Direct |
1,600
+34.04%
|
$4,800
$3.13 P/Share
|
|
Jul 31
2024
|
Vanessa Carle Secretary |
SELL
Open market or private sale
|
Direct |
2,567
-100.0%
|
$10,268
$4.0 P/Share
|
|
May 14
2024
|
Vanessa Carle Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+49.34%
|
$2,500
$1.15 P/Share
|
|
Feb 09
2023
|
Catherine C. Turkel Director |
BUY
Open market or private purchase
|
Direct |
1,500
+50.0%
|
$3,000
$2.84 P/Share
|
|
Oct 14
2022
|
Gregory Downey Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
121
+5.83%
|
$242
$2.09 P/Share
|
|
Oct 13
2022
|
Christopher Bunka Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
16,600
+6.13%
|
$33,200
$2.1 P/Share
|
|
Oct 12
2022
|
Christopher Bunka Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
21,900
+8.43%
|
$21,900
$1.99 P/Share
|
|
May 24
2022
|
Albert L Reese Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,000
+31.41%
|
$5,000
$1.96 P/Share
|
|
May 20
2022
|
Albert L Reese Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,799
+23.32%
|
$3,598
$2.01 P/Share
|
|
May 19
2022
|
Albert L Reese Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,501
+26.71%
|
$3,002
$2.01 P/Share
|
|
May 18
2022
|
Albert L Reese Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,700
+39.38%
|
$3,400
$2.01 P/Share
|
|
Nov 10
2020
|
Christopher Bunka Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
41,500
+0.21%
|
$0
$0.2 P/Share
|
|
Nov 09
2020
|
Christopher Bunka Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
94,000
+0.24%
|
$0
$0.21 P/Share
|
|
Nov 06
2020
|
Christopher Bunka Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
60,000
+0.94%
|
$0
$0.21 P/Share
|